Overview
Hyperphenylalaninemia due to tetrahydrobiopterin (BH4) deficiency is a rare inherited metabolic disorder that causes high levels of the amino acid phenylalanine in the blood. Unlike classic phenylketonuria (PKU), which is caused by a problem with the enzyme that breaks down phenylalanine, this condition is caused by the body's inability to make or recycle tetrahydrobiopterin — a small molecule that is essential for several important enzymes to work properly. BH4 is needed not only to break down phenylalanine but also to produce key brain chemicals (neurotransmitters) such as dopamine and serotonin. Because of this, the disease affects both metabolism and brain function. Symptoms typically appear in the first months of life and can include developmental delay, movement problems, seizures, difficulty swallowing, and abnormal muscle tone. Without treatment, the condition can lead to severe intellectual disability and progressive neurological decline. Newborn screening programs can detect elevated phenylalanine levels shortly after birth, but additional testing is needed to distinguish BH4 deficiency from classic PKU. Treatment involves supplementing BH4 (sapropterin), replacing the missing neurotransmitter precursors (such as L-DOPA and 5-hydroxytryptophan), and sometimes following a low-phenylalanine diet. Early diagnosis and prompt treatment are critical to achieving the best possible outcomes. With appropriate lifelong therapy, many patients can experience significant improvement, though the degree of benefit depends on the specific type and severity of the deficiency.
Also known as:
Key symptoms:
Developmental delayIntellectual disabilitySeizuresAbnormal muscle tone (too stiff or too floppy)Movement problems such as tremors or involuntary movementsDifficulty swallowingExcessive droolingIrritabilityPoor head controlSleep disturbancesTemperature instabilitySlow growthBehavioral problemsEpisodes of drowsiness or lethargy
Clinical phenotype terms (24)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.
Community
No community posts yet. Be the first to share your experience with Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.
Start the conversation →Latest news about Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
No recent news articles for Hyperphenylalaninemia due to tetrahydrobiopterin deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific type of BH4 deficiency does my child have, and which gene is affected?,What medications will my child need, and how often do doses need to be adjusted?,How will we monitor whether the treatment is working well enough?,Does my child need a special diet, and if so, how strict does it need to be?,What developmental outcomes can we realistically expect with treatment?,Are there any clinical trials or new therapies being studied for this condition?,What should I do if my child has a seizure or a sudden change in behavior or movement?
Common questions about Hyperphenylalaninemia due to tetrahydrobiopterin deficiency
What is Hyperphenylalaninemia due to tetrahydrobiopterin deficiency?
Hyperphenylalaninemia due to tetrahydrobiopterin (BH4) deficiency is a rare inherited metabolic disorder that causes high levels of the amino acid phenylalanine in the blood. Unlike classic phenylketonuria (PKU), which is caused by a problem with the enzyme that breaks down phenylalanine, this condition is caused by the body's inability to make or recycle tetrahydrobiopterin — a small molecule that is essential for several important enzymes to work properly. BH4 is needed not only to break down phenylalanine but also to produce key brain chemicals (neurotransmitters) such as dopamine and serot
How is Hyperphenylalaninemia due to tetrahydrobiopterin deficiency inherited?
Hyperphenylalaninemia due to tetrahydrobiopterin deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hyperphenylalaninemia due to tetrahydrobiopterin deficiency typically begin?
Typical onset of Hyperphenylalaninemia due to tetrahydrobiopterin deficiency is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Hyperphenylalaninemia due to tetrahydrobiopterin deficiency?
2 specialists and care centers treating Hyperphenylalaninemia due to tetrahydrobiopterin deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.